Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locally Advanced Pancreatic Cancer
NCT00149578Phase 2Unknown
- Sponsor
- National Health Research Institutes
- Start
- Oct 2004
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine, oxaliplatin, fluorouracil and folinic acid in pancreatic cancer (PC), sponsored by National Health Research Institutes. Primary endpoint: Local Response Rate. Status: unknown.
02
Drugs
gemcitabineoxaliplatinfluorouracilfolinic acid
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00149578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00149578.